Nikang Therapeutics

Nikang Therapeutics is a clinical-stage biotech company based in Wilmington, DE, dedicated to developing innovative small molecule drugs. The company's research focuses on disease biology insights and structure-based drug design, with a current focus on HIF2α, CDK2, and KRAS. Nikang Therapeutics aims to address unmet medical needs, particularly in the field of cancer, through the development of precision medicine.